Cencora completes acquisition of Retina Consultants of America

Cencora announced the completion of its acquisition of Retina Consultants of America, a management services organization of retina specialists.

Cencora has acquired an interest in RCA of approximately 85%, with certain RCA physicians and members of the management team retaining a minority equity interest in the company. The acquisition allows Cencora to build on its leadership in specialty, expand its MSO solutions and drive differentiated value for stakeholders, including physicians and patients, the company said.

[Read more: Cencora intros Accelerate Pharmacy Solutions]

Cencora has updated its fiscal year 2025 financial guidance to reflect the expected contribution from the closing of the RCA acquisition and also continued momentum in the U.S. Healthcare Solutions reportable segment. The company now expects adjusted diluted earnings per share to be in the range of $15.15 to $15.45, raised from the previous range of $14.80 to $15.10.

[Watch DSN: Cencora, Good Neighbor Pharmacy look to pharmacists to fill in care gaps